Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association
Aims: The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2024
|
| _version_ | 1826313673822437376 |
|---|---|
| author | Sterliński, M Bunting, KV Boriani, G Boveda, S Guasch, E Mont, L Rajappan, K Sommer, P Mehta, S Sun, Y Gale, CP van Deutekom, C Van Gelder, IC Kotecha, D STEEER-AF Trial Team |
| author_facet | Sterliński, M Bunting, KV Boriani, G Boveda, S Guasch, E Mont, L Rajappan, K Sommer, P Mehta, S Sun, Y Gale, CP van Deutekom, C Van Gelder, IC Kotecha, D STEEER-AF Trial Team |
| author_sort | Sterliński, M |
| collection | OXFORD |
| description | Aims: The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) trial. Methods and results: STEEER-AF is a pragmatic trial designed to objectively and robustly determine whether guidelines are adhered to in routine practice and evaluate a targeted educational programme for healthcare professionals. Seventy centres were randomized in six countries (France, Germany, Italy, Poland, Spain, and UK; 2022–23). The STEEER-AF centres recruited 1732 patients with a diagnosis of atrial fibrillation (AF), with a mean age of 68.9 years (SD 11.7), CHA2DS2-VASc score of 3.2 (SD 1.8), and 647 (37%) women. Eight hundred and forty-three patients (49%) were in AF at enrolment and 760 (44%) in sinus rhythm. Oral anticoagulant therapy was prescribed in 1543 patients (89%), with the majority receiving direct oral anticoagulants (1378; 89%). Previous cardioversion, antiarrhythmic drug therapy, or ablation was recorded in 836 patients (48.3%). Five hundred fifty-one patients (31.8%) were currently receiving an antiarrhythmic drug, and 446 (25.8%) were scheduled to receive a future cardioversion or ablation. The educational programme engaged 195 healthcare professionals across centres randomized to the intervention group, consisting of bespoke interactive online learning and reinforcement activities, supported by national expert trainers. Conclusion: The STEEER-AF trial was successfully deployed across six European countries to investigate guideline adherence in real-world practice and evaluate if a structured educational programme for healthcare professionals can improve patient-level care. Clinical Trial Registration: Clinicaltrials.gov, NCT04396418. |
| first_indexed | 2024-09-25T04:18:44Z |
| format | Journal article |
| id | oxford-uuid:50abd45b-6c44-4a4a-af56-b3ec74a5a515 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:18:44Z |
| publishDate | 2024 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:50abd45b-6c44-4a4a-af56-b3ec74a5a5152024-07-31T19:36:34ZDesign and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm AssociationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:50abd45b-6c44-4a4a-af56-b3ec74a5a515EnglishJisc Publications RouterOxford University Press2024Sterliński, MBunting, KVBoriani, GBoveda, SGuasch, EMont, LRajappan, KSommer, PMehta, SSun, YGale, CPvan Deutekom, CVan Gelder, ICKotecha, DSTEEER-AF Trial Team Aims: The aim is to describe the rationale, design, delivery, and baseline characteristics of the Stroke prevention and rhythm control Treatment: Evaluation of an Educational programme of the European society of cardiology in a cluster-Randomized trial in patients with Atrial Fibrillation (STEEER-AF) trial. Methods and results: STEEER-AF is a pragmatic trial designed to objectively and robustly determine whether guidelines are adhered to in routine practice and evaluate a targeted educational programme for healthcare professionals. Seventy centres were randomized in six countries (France, Germany, Italy, Poland, Spain, and UK; 2022–23). The STEEER-AF centres recruited 1732 patients with a diagnosis of atrial fibrillation (AF), with a mean age of 68.9 years (SD 11.7), CHA2DS2-VASc score of 3.2 (SD 1.8), and 647 (37%) women. Eight hundred and forty-three patients (49%) were in AF at enrolment and 760 (44%) in sinus rhythm. Oral anticoagulant therapy was prescribed in 1543 patients (89%), with the majority receiving direct oral anticoagulants (1378; 89%). Previous cardioversion, antiarrhythmic drug therapy, or ablation was recorded in 836 patients (48.3%). Five hundred fifty-one patients (31.8%) were currently receiving an antiarrhythmic drug, and 446 (25.8%) were scheduled to receive a future cardioversion or ablation. The educational programme engaged 195 healthcare professionals across centres randomized to the intervention group, consisting of bespoke interactive online learning and reinforcement activities, supported by national expert trainers. Conclusion: The STEEER-AF trial was successfully deployed across six European countries to investigate guideline adherence in real-world practice and evaluate if a structured educational programme for healthcare professionals can improve patient-level care. Clinical Trial Registration: Clinicaltrials.gov, NCT04396418. |
| spellingShingle | Sterliński, M Bunting, KV Boriani, G Boveda, S Guasch, E Mont, L Rajappan, K Sommer, P Mehta, S Sun, Y Gale, CP van Deutekom, C Van Gelder, IC Kotecha, D STEEER-AF Trial Team Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title | Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title_full | Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title_fullStr | Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title_full_unstemmed | Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title_short | Design and deployment of the STEEER-AF trial to evaluate and improve guideline adherence: a cluster-randomized trial by the European Society of Cardiology and European Heart Rhythm Association |
| title_sort | design and deployment of the steeer af trial to evaluate and improve guideline adherence a cluster randomized trial by the european society of cardiology and european heart rhythm association |
| work_keys_str_mv | AT sterlinskim designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT buntingkv designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT borianig designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT bovedas designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT guasche designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT montl designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT rajappank designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT sommerp designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT mehtas designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT suny designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT galecp designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT vandeutekomc designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT vangelderic designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT kotechad designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation AT steeeraftrialteam designanddeploymentofthesteeeraftrialtoevaluateandimproveguidelineadherenceaclusterrandomizedtrialbytheeuropeansocietyofcardiologyandeuropeanheartrhythmassociation |